Transcend Capital Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

Transcend Capital Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 12,722 shares of TEVA stock, worth $216,655. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,722

Previous 12,646 0.6%

Holding current value

$216,655

Previous $205,000 11.71%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$15.81 - $18.96 $1,201 - $1,440	76 Added 0.6%	12,722 $229,000
Q2 2024 Jul 02, 2024	BUY	$12.78 - $17.4 $2,504 - $3,410	196 Added 1.57%	12,646 $205,000
Q1 2024 May 03, 2024	SELL	$10.67 - $14.43 $992 - $1,341	-93 Reduced 0.74%	12,450 $175,000
Q4 2023 Feb 05, 2024	BUY	$8.12 - $10.63 $12,179 - $15,945	1,500 Added 13.58%	12,543 $130,000
Q1 2023 Apr 12, 2023	SELL	$8.36 - $11.37 $15,883 - $21,603	-1,900 Reduced 14.68%	11,043 $97,000
Q4 2022 Jan 20, 2023	BUY	$7.95 - $9.48 $739 - $881	93 Added 0.72%	12,943 $0
Q1 2022 Apr 20, 2022	BUY	$7.33 - $9.39 $13,927 - $17,841	1,900 Added 17.35%	12,850 $121,000
Q4 2021 Jan 20, 2022	SELL	$7.9 - $10.19 $1,185 - $1,528	-150 Reduced 1.35%	10,950 $88,000
Q3 2021 Nov 04, 2021	SELL	$8.38 - $10.18 $4,583 - $5,568	-547 Reduced 4.7%	11,100 $104,000
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $5,415 - $6,323	547 Added 4.93%	11,647 $114,000
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $95,127 - $140,859	11,100 New	11,100 $100,000
Q2 2020 Aug 05, 2020	SELL	$8.12 - $13.12 $88,913 - $143,664	-10,950 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$6.69 - $13.45 $73,255 - $147,277	10,950 New	10,950 $98,000

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History